Gel Formulation of Infigratinib for Intravesical use in Non-muscle Invasive Bladder Cancer (NMIBC)

Project Details

Short titleGel Formulation of Infigratinib for Intravesical use in Non-muscle Invasive Bladder Cancer (NMIBC)
StatusFinished
Effective start/end date4/12/203/06/22

Funding

  • QED Therapeutics